Physician profile
Todd M Thomas
NPI 1891173555
$10,332.00
in general payments reported to CMS, 2019-2025
26 companies · $1,461 in 2025
The $1,461 reported for 2025 was more than what 90% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,194 · 2020: $1,683 · 2021: $1,005 · 2022: $2,372 · 2023: $1,192 · 2024: $1,424 · 2025: $1,461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,077.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,076.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,324.12 | 2021-2024 | Corevalve Evolut R, Micra |
| Abiomed | $1,871.19 | 2019-2025 | Impella |
| Boston Scientific Corporation | $1,416.55 | 2019-2025 | General - Balloon Catheters |
| Abbott Laboratories | $794.89 | 2019-2025 | Cardiomems, Perclose Prostyle, Amplatzer Talisman |
| Inari Medical, INC. | $740.05 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $507.04 | 2019-2024 | Lifevest |
| Philips North America LLC | $422.39 | 2019-2024 | (5153) Azurion 5 M20 Gc, (Br5) Peripheral Ivus |
| E.R. Squibb & Sons, L.L.C. | $289.68 | 2019-2025 | Camzyos, Eliquis |
| Stryker Corporation | $282.46 | 2025 | Artix Mt, Clottriever Bold Catheter, Ct Thrombectomy System Kit |
| Astrazeneca Pharmaceuticals LP | $249.68 | 2019-2024 | Farxiga |
| Penumbra, INC. | $204.21 | 2023 | Indigo System |
| Edwards Lifesciences Corporation | $182.96 | 2022 | |
| Cardiovascular Systems INC. | $176.15 | 2019-2021 | |
| Silk Road Medical, INC. | $143.09 | 2022 | |
| Janssen Pharmaceuticals, INC | $107.15 | 2019-2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $103.78 | 2019 | |
| Lundbeck LLC | $99.64 | 2019 | |
| Terumo Medical Corporation | $86.20 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $83.51 | 2019 | |
| Amgen INC. | $62.64 | 2019-2025 | Repatha |
| Ge Healthcare | $61.98 | 2025 | |
| Imperative Care, INC | $46.23 | 2024 | Symphony Catheter |
| Innovation Technologies INC | $26.94 | 2025 | Irrisept |
| Biosense Webster, INC. | $18.86 | 2019 | |
| Irhythm Technologies, INC. | $17.79 | 2024 | Zio Xt Patch, Zio Monitor |
| Regeneron Healthcare Solutions, INC. | $12.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.